Different Metabolism of EPA, DPA and DHA in humans: a double-blind cross-over study
Considerable research supporting the beneficial biological effects of n-3 long-chain polyunsaturated fatty acids (LCP) have shown that these LCP contribute to preventing and improving chronic disease outcomes, including metabolic disease, cardiovascular diseases (CVD), non-alcoholic fatty liver disease and some kinds of cancers [1-3]. A large proportion of these studies have focused on fish oils, which commonly contain three kinds of n-3 LCP, namely eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA).
Source: Prostaglandins, Leukotrienes and Essential Fatty Acids - Category: Biomedical Science Authors: Xiao-fei Guo, Wen-feng Tong, Yue Ruan, Andrew J. Sinclair, Duo Li Source Type: research
More News: Alcoholism | Biomedical Science | Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Fatty Liver Disease (FLD) | Fish | Heart | Liver | Liver Disease | Non-alcoholic Fatty Liver Diseases (NAFLD) | Study | Urology & Nephrology